Turning Point Therapeutics, Inc.
TPTX · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $428 | $554 | $48 | $101 |
| Short-Term Investments | $554 | $568 | $361 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $8 | $6 | $0 |
| Total Curr. Assets | $992 | $1,131 | $415 | $102 |
| Property Plant & Equip (Net) | $9 | $6 | $7 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $0 | $0 | $1 |
| Total NC Assets | $11 | $6 | $7 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,003 | $1,137 | $422 | $103 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $2 | $1 |
| Short-Term Debt | $4 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $38 | $18 | $11 | $4 |
| Total Curr. Liab. | $47 | $24 | $14 | $5 |
| LT Debt | $2 | $2 | $4 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $2 | $4 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $49 | $27 | $18 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $422 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$517 | -$280 | -$123 | -$51 |
| AOCI | -$1 | $0 | $0 | -$0 |
| Other Equity | $1,472 | $1,390 | $105 | $149 |
| Total Equity | $954 | $1,110 | $404 | $98 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,003 | $1,137 | $422 | $103 |
| Net Debt | -$422 | -$550 | -$43 | -$101 |